相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGF beta 1 action and upregulating MMP14
Eszter Regos et al.
MATRIX BIOLOGY (2018)
Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-beta 1 secretion
Yu Ren et al.
MOLECULAR CANCER (2018)
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity
Antoun Al Absi et al.
CANCER RESEARCH (2018)
Inflammatory breast cancer biology: the tumour microenvironment is key
Bora Lim et al.
NATURE REVIEWS CANCER (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Tomasz Ahrends et al.
IMMUNITY (2017)
Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps
Guo-qing Gong et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2017)
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Sherif Abdelaziz Ibrahim et al.
MOLECULAR CANCER (2017)
Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier?
Irma Tindemans et al.
FRONTIERS IN IMMUNOLOGY (2017)
RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
Gerd Meyer zu Horste et al.
CELL REPORTS (2016)
Notch regulates Th17 differentiation and controls trafficking of IL-17 and metabolic regulators within Th17 cells in a context-dependent manner
Manuel Coutaz et al.
SCIENTIFIC REPORTS (2016)
Syndecan-1 identifies and controls the frequency of IL-17-producing naive natural killer T (NKT17) cells in mice
Hong Dai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
The role of the cell-cell interactions in cancer progression
Katarzyna Kaminska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease
Thomas Welte et al.
MEDIATORS OF INFLAMMATION (2015)
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
Maija Hollmen et al.
SCIENTIFIC REPORTS (2015)
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
Stephen L. Shiao et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Syndecan-1 and Its Expanding List of Contacts
Mary Ann Stepp et al.
ADVANCES IN WOUND CARE (2015)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa et al.
BREAST CANCER RESEARCH (2015)
The immune system and inflammation in breast cancer
Xinguo Jiang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Hebatallah Hassan et al.
FEBS JOURNAL (2013)
Syndecan-1, a Cell Surface Proteoglycan, Negatively Regulates Initial Leukocyte Recruitment to the Brain across the Choroid Plexus in Murine Experimental Autoimmune Encephalomyelitis
Xueli Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
Sherif A. Ibrahim et al.
PLOS ONE (2013)
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2
Stephanie Cochaud et al.
SCIENTIFIC REPORTS (2013)
Syndecan-1 Displays a Protective Role in Aortic Aneurysm Formation by Modulating T Cell-Mediated Responses
Jiantao Xiao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling
Ruben L. Smeets et al.
BMC IMMUNOLOGY (2012)
Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism
Sherif A. Ibrahim et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ
Herbert Fluhr et al.
FERTILITY AND STERILITY (2011)
Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach
Mohamed El-Shinawi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Enrichment of CCR6(+)Foxp3(+) regulatory T cells in the tumor mass correlates with impaired CD8(+) T cell function and poor prognosis of breast cancer
Lin Xu et al.
CLINICAL IMMUNOLOGY (2010)
Higher levels of GATA3 predict better survival in women with breast cancer
Nam K. Yoon et al.
HUMAN PATHOLOGY (2010)
Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells
Xinming Su et al.
JOURNAL OF IMMUNOLOGY (2010)
Up for Mischief? IL-17/Th17 in the tumour microenvironment
E. Maniati et al.
ONCOGENE (2010)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Viktoriya Nikolova et al.
CARCINOGENESIS (2009)
Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
Behzad Kharabi Masouleh et al.
JOURNAL OF IMMUNOLOGY (2009)
Regulation of T Cell Activation by Notch Ligand, DLL4, Promotes IL-17 Production and Rorc Activation
Sumanta Mukherjee et al.
JOURNAL OF IMMUNOLOGY (2009)
GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis
A. B. Dydensborg et al.
ONCOGENE (2009)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
Cytokine-based transformation of immune surveillance into tumor-promoting inflammation
J. B. Mumm et al.
ONCOGENE (2008)
Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-β(TGF-β) by modulating assembly of latent TGF-β-binding protein-1
Qian Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reduced migration, altered matrix and enhanced TGFβ1 signaling are signatures of mouse keratinocytes lacking Sdc1
Mary Ann Stepp et al.
JOURNAL OF CELL SCIENCE (2007)
Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
Sachin Gupta et al.
ACTA ONCOLOGICA (2007)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype
Fusun Baba et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Heparin/heparan sulphate binding in the TGF-β cytokine superfamily
CC Rider
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription
T Usui et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Endogenous attenuation of allergic lung inflammation by syndecan-1
J Xu et al.
JOURNAL OF IMMUNOLOGY (2005)
TGF-β induces Foxp3+T-regulatory cells from CD4+CD25-precursors
S Fu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The function role of GATA-3 in Th1 and Th2 differentiation
M Zhou et al.
IMMUNOLOGIC RESEARCH (2003)
The two faces of IL-6 on Th1/Th2 differentiation
S Diehl et al.
MOLECULAR IMMUNOLOGY (2002)
Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells
IH Heijink et al.
IMMUNOLOGY (2002)
分享论文
